The Oncologist eJournal Named PM360 Trailblazer Finalist for Initiatives – App Launch

Share Article

PM360, a monthly magazine for marketing decision-makers in the pharmaceutical, biotech, and medical device industries, recently named The Oncologist eJournal as a Trailblazer Initiatives - App Launch finalist.

The Oncologist App

Physicians have a very limited amount of time, so we are putting the same trusted and critical information from our journals at their fingertips, on-demand.

PM360, a monthly magazine for marketing decision-makers in the pharmaceutical, biotech, and medical device industries, recently named The Oncologist eJournal as a Trailblazer Initiatives - App Launch finalist.

In response to increasing time demands and the growing use of mobile technology among physicians, The Oncologist developed a dynamic and engaging new app to facilitate quick and easy access to peer-reviewed medical information and key opinion leader podcasts for oncology professionals worldwide. The Oncologist eJournal App for iPad allows users to virtually flip through journal pages, accessing critical articles in seconds. The Oncologist eJournal App was the first in its classification to provide full-text articles while allowing physicians a mobile platform that is both searchable and ready for social networking.

“Our mission is to foster the best cancer patient care and practice management,” said Marty Murphy, 3rd, AlphaMed Press Vice President, Global Business Development. “Physicians have a very limited amount of time, so we are putting the same trusted and critical information from our journals at their fingertips, on-demand. All of the Journal’s content and resources can be immediately retrieved wherever they are!"

Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Winning initiatives were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on content, format, success in reaching targeted audience, and overall quality.

“The PM360 Trailblazer Awards recognize the industry’s best companies, initiatives, and individuals,” said Anna Stashower, editor and publisher. “Trailblazers are not afraid to take risks, explore new marketing approaches, or implement groundbreaking tactics. They display outstanding leadership qualities, innovative thinking, and dedication to improving patient lives.”

This year’s awards will be announced at a gala on September 9th at the Mandarin Oriental Hotel Ballroom and winners will be featured in the October issue of PM360. Tony Jewell, senior director of AstraZeneca Pharmaceuticals—last year’s Best Pharma Company winner—will deliver a keynote speech on strategies for maintaining innovation at AZ.

Contact: Marty Murphy, 3rd, VP Global Business Development, (303) 257-6315; marty3rd(at)alphamedpress(dot)com

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA and Belfast, United Kingdom publishes two internationally renowned peer-reviewed journals: STEM CELLS®, now in its 29th year, is the world's first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, is in its 16th year and is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. Both journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. In January 2012, AlphaMed Press will launch a new peer-reviewed journal, STEM CELLS Translational Medicine, that will hasten the clinical applications of stem cell therapies.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sharon Lee
AlphaMed Press
919.680.0011 230
Email >